Skip to content

Clinical trials

Completed Phase 1/2 Metabolic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Phase: Phase 1/2 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20134
20142
20151
20161
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
LYSOGENE2
89bio, Inc.1
Alexion Pharmaceuticals, Inc.1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
James J. Peters Veterans Affairs Medical Center1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Mesoblast, Ltd.1
Stem Cells Arabia1
Ultragenyx Pharmaceutical Inc1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases11
Genetic Diseases, Inborn3
Mucopolysaccharidosis III3
Obesity3
Diabetes Mellitus, Type 22
Lysosomal Storage Diseases2
Neurodegenerative Diseases2
Non-alcoholic Fatty Liver Disease2
Autoimmune Diseases1
Carbohydrate Metabolism, Inborn Errors1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.